4.3 Review

Novel Sequencing-based Strategies for High-Throughput Discovery of Genetic Mutations Underlying Inherited Antibody Deficiency Disorders

Journal

CURRENT ALLERGY AND ASTHMA REPORTS
Volume 11, Issue 5, Pages 352-360

Publisher

CURRENT MEDICINE GROUP
DOI: 10.1007/s11882-011-0211-x

Keywords

High-throughput sequencing; Microarray; Next-generation sequencing; Target sequence enrichment; Sequence capture by hybridization; PCR; Cost-effective; Assay development

Funding

  1. National Institutes of Health/National Institute of Allergy and Infectious Diseases

Ask authors/readers for more resources

Human inherited antibody deficiency disorders are generally caused by mutations in genes involved in the pathways regulating B-cell class switch recombination; DNA damage repair; and B-cell development, differentiation, and survival. Sequencing a large set of candidate genes involved in these pathways appears to be a highly efficient way to identify novel mutations. Herein we review several high-throughput sequencing approaches as well as recent improvements in target gene enrichment technologies. Systematic improvement of enrichment and sequencing methods, along with refinement of the experimental process is necessary to develop a cost-effective high-throughput resequencing assay for a large cohort of patient samples. The Hyper-IgM/CVID chip is one example of a resequencing platform that may be used to identify known or novel mutations in patents with various types of inherited antibody deficiency.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available